PAPAartis Secures German Research Foundation Funding

The German Research Foundation (DFG) has awarded the PAPAartis project an additional research grant of €2.3M to improve and enlarge the European Horizon 2020 trial.

We are pleased to announce that the project will be able to now welcome 13 new trial sites from Germany and Austria on board. With their help, the PAPAartis project will now be able to recruit an additional 200 patients, giving a total recruitment of 500 patients of Crawford types II and III.